{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:34:05Z","timestamp":1769603645572,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:00:00Z","timestamp":1491609600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00428-017-2121-3","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T11:33:51Z","timestamp":1491651231000},"page":"687-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cutaneous basal cell carcinoma with distant metastasis to thorax and bone"],"prefix":"10.1007","volume":"470","author":[{"given":"Annikka","family":"Weissferdt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Kalhor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar A.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,8]]},"reference":[{"key":"2121_CR1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1055-3207(18)30319-3","volume":"6","author":"SK Barksdale","year":"1997","unstructured":"Barksdale SK, O\u2019Connor N, Barnhill R (1997) Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am 6:625\u2013638","journal-title":"Surg Oncol Clin N Am"},{"key":"2121_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13671-014-0069-y","volume":"3","author":"SV Mohan","year":"2014","unstructured":"Mohan SV, Chang AL (2014) Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep 3:40\u201345","journal-title":"Curr Dermatol Rep"},{"key":"2121_CR3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0190-9622(08)81509-5","volume":"30","author":"DL Miller","year":"1994","unstructured":"Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774\u2013778","journal-title":"J Am Acad Dermatol"},{"key":"2121_CR4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","volume":"10","author":"H Domarus von","year":"1984","unstructured":"von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10:1043\u20131060","journal-title":"J Am Acad Dermatol"},{"key":"2121_CR5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamadermatol.2013.3064","volume":"149","author":"A Wysong","year":"2013","unstructured":"Wysong A, Aasi SZ, Tang JY (2013) Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol 149:615\u2013616","journal-title":"JAMA Dermatol"},{"key":"2121_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/B:CANC.0000031775.04618.30","volume":"23","author":"HW Walling","year":"2004","unstructured":"Walling HW, Fosko SW, Geraminejad PA et al (2004) Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 23:389\u2013402","journal-title":"Cancer Metastasis Rev"},{"key":"2121_CR7","first-page":"255","volume":"22","author":"HW Randle","year":"1996","unstructured":"Randle HW (1996) Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg 22:255\u2013261","journal-title":"Dermatol Surg"},{"key":"2121_CR8","first-page":"906","volume":"109","author":"R Jackson","year":"1973","unstructured":"Jackson R (1973) Early clinical descriptions of skin cancer. Can Med Assoc J 109:906\u2013908","journal-title":"Can Med Assoc J"},{"key":"2121_CR9","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.oooo.2012.04.030","volume":"117","author":"S Moser","year":"2014","unstructured":"Moser S, Borm J, Mihic-Probst D et al (2014) Metastatic basal cell carcinoma: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol 117:e79\u2013e82","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2121_CR10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(19800815)46:4<748::AID-CNCR2820460419>3.0.CO;2-K","volume":"46","author":"ER Farmer","year":"1980","unstructured":"Farmer ER, Helwig EB (1980) Metastatic basal cell carcinoma: a clinicopathologic study of seventeen cases. Cancer 46:748\u2013757","journal-title":"Cancer"},{"key":"2121_CR11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ctrv.2010.12.002","volume":"37","author":"AK Ganti","year":"2011","unstructured":"Ganti AK, Kessinger A (2011) Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treat Rev 37:440\u2013443","journal-title":"Cancer Treat Rev"},{"key":"2121_CR12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jid.2012.403","volume":"133","author":"MM Chren","year":"2013","unstructured":"Chren MM, Linos E, Torres JS et al (2013) Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 133:1188\u20131196","journal-title":"J Invest Dermatol"},{"key":"2121_CR13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1346-8138.2011.01494.x","volume":"39","author":"S Ansai","year":"2012","unstructured":"Ansai S, Takayama R, Kimura T et al (2012) Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms. J Dermatol 39:688\u2013692","journal-title":"J Dermatol"},{"key":"2121_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.anndiagpath.2015.01.004","volume":"19","author":"DV Webb","year":"2015","unstructured":"Webb DV, Mentrikoski MJ, Verduin L et al (2015) Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal. Ann Diagn Pathol 19:70\u201375","journal-title":"Ann Diagn Pathol"},{"key":"2121_CR15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00000372-199310000-00007","volume":"15","author":"O Tellechea","year":"1993","unstructured":"Tellechea O, Reis JP, Domingues JC et al (1993) Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 15:452\u2013455","journal-title":"Am J Dermatopathol"},{"key":"2121_CR16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.7314\/APJCP.2016.17.3.1379","volume":"17","author":"M Ramezani","year":"2016","unstructured":"Ramezani M, Mohamadzaheri E, Khazaei S et al (2016) Comparison of EMA,CEA, CD10 and Bcl-2 biomarkers by immunohistochemistry in squamous cell carcinoma and basal cell carcinoma of the skin. Asian Pac J Cancer Prev 17:1379\u20131383","journal-title":"Asian Pac J Cancer Prev"},{"key":"2121_CR17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjd.12333","volume":"169","author":"C Danial","year":"2013","unstructured":"Danial C, Lingala B, Balise R et al (2013) Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma. Br J Dermatol 169:673\u2013676","journal-title":"Br J Dermatol"},{"key":"2121_CR18","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","volume":"366","author":"A Sekulic","year":"2012","unstructured":"Sekulic A, Migden MR, Oro AE et al (2012) Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 366:2171\u20132179","journal-title":"N Engl J Med"},{"key":"2121_CR19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaad.2015.03.021","volume":"72","author":"A Sekulic","year":"2015","unstructured":"Sekulic A, Migden MR, Lewis K et al (2015) ERIVANCE BCC investigators. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol 72:1021\u20136.e8","journal-title":"J Am Acad Dermatol"},{"key":"2121_CR20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","volume":"16","author":"MR Migden","year":"2015","unstructured":"Migden MR, Guminski A, Gutzmer R et al (2015) Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol 16:716\u2013728","journal-title":"Lancet Oncol"},{"key":"2121_CR21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0303-6987.2006.00436.x","volume":"33","author":"S Bircan","year":"2006","unstructured":"Bircan S, Candir O, Kapucoglu N et al (2006) The expression of p63 in basal cell carcinomas and association with histological differentiation. J Cutan Pathol 33:293\u2013298","journal-title":"J Cutan Pathol"},{"key":"2121_CR22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/PAI.0000000000000204","volume":"24","author":"JH Andruszkow","year":"2016","unstructured":"Andruszkow JH, Oll M, F\u00f6rster S et al (2016) p40 in conjunction with CK20 and e-cadherin distinguishes primary adnexal neoplasms of the skin. Appl Immunohistochem Mol Morphol 24:414\u2013421","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2121_CR23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D331K5T125","volume":"15","author":"M Krokowski","year":"2009","unstructured":"Krokowski M, Hoch J, Feller AC et al (2009) Basal cell carcinoma with neuroendocrine differentiation arising in a scar: a case report. Dermatol Online J 15:4","journal-title":"Dermatol Online J"},{"key":"2121_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0344-0338(11)80560-1","volume":"191","author":"G Jundt","year":"1995","unstructured":"Jundt G, Remberger K, Roessner A et al (1995) Adamantinoma of long bones. A histopathological and immunohistochemical study of 23 cases. Pathol Res Pract 191:112\u2013120","journal-title":"Pathol Res Pract"},{"key":"2121_CR25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1440-1827.2000.01114.x","volume":"50","author":"M Maki","year":"2000","unstructured":"Maki M, Saitoh K, Kaneko Y et al (2000) Expression of cytokeratin 1, 5, 14, 19 and transforming growth factors-beta1, beta2, beta3 in osteofibrous dysplasia and adamantinoma: a possible association of transforming growth factor-beta with basal cell phenotype promotion. Pathol Int 50:801\u2013807","journal-title":"Pathol Int"},{"key":"2121_CR26","first-page":"1246","volume":"12","author":"O Hamid","year":"2013","unstructured":"Hamid O, Goldenberg G (2013) Identifying patients at risk for recurrent or advanced BCC. J Drugs Dermatol 12:1246\u20131252","journal-title":"J Drugs Dermatol"},{"key":"2121_CR27","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMra044151","volume":"353","author":"AI Rubin","year":"2005","unstructured":"Rubin AI, Chen EH, Ratner D (2005) Basal cell carcinoma. N Engl J Med 353:2262\u20132269","journal-title":"N Engl J Med"},{"key":"2121_CR28","first-page":"394","volume":"16","author":"M Dandurand","year":"2006","unstructured":"Dandurand M, Petit T, Martel P et al (2006) Management of basal cell carcinoma in adults. Clinical practice guidelines. Eur J Dermatol 16:394\u2013401","journal-title":"Eur J Dermatol"},{"key":"2121_CR29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ceo.12298","volume":"42","author":"A Wu","year":"2014","unstructured":"Wu A, Sun MT, Huilgol SC et al (2014) Histological subtypes of periocular basal cell carcinoma. Clin Exp Ophthalmol 42:603\u2013607","journal-title":"Clin Exp Ophthalmol"},{"key":"2121_CR30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12094-014-1272-9","volume":"17","author":"S Puig","year":"2015","unstructured":"Puig S, Berrocal A (2015) Management of high-risk and advanced basal cell carcinoma. Clin Transl Oncol 17:497\u2013503","journal-title":"Clin Transl Oncol"},{"key":"2121_CR31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/IOP.0000000000000372","volume":"31","author":"MT Sun","year":"2015","unstructured":"Sun MT, Wu A, Huilgol SC et al (2015) Accuracy of biopsy in subtyping periocular basal cell carcinoma. Ophthal Plast Reconstr Surg 31:449\u2013451","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-017-2121-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2121-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2121-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:07:08Z","timestamp":1692756428000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-017-2121-3"}},"subtitle":["A clinicopathological and immunohistochemical study of 15 cases"],"short-title":[],"issued":{"date-parts":[[2017,4,8]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s00428-017-2121-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,8]]}}}